NSE: DIVISLAB

Divi's Laboratories: Scaling New Heights in the Global Pharma Arena

By StreetVantage Intelligence // November 2, 2026

₹₹9,939.50

BULLISH

DISCLAIMER: Educational intelligence only. StreetVantage is NOT SEBI registered. Trading involve risk of loss.